Fundraising FoxSlater Technology Fund — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
Prothera Biologicsprotherabiologics.comNov 2015
ProThera Biologics develops therapies based on Inter-alpha inhibitor proteins (IAIP), a class of human plasma proteins with anti-inflammatory activity, to treat patients with severe inflammatory diseases.
BiotechHealthtechProvidence, US
Yow-Pin Lim(Founder and Chief Executive Officer)inDenice Spero(Executive Officer)Douglas C. Hixson(Director)
BoardRichard G. Horan(Director)Richard A. Andrews(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.